Literature DB >> 26059843

Xp11.2 microduplications including IQSEC2, TSPYL2 and KDM5C genes in patients with neurodevelopmental disorders.

Ching Moey1,2, Susan J Hinze1,2, Louise Brueton3, Jenny Morton3, Dominic J McMullan4, Benjamin Kamien5, Christopher P Barnett6, Nicola Brunetti-Pierri7,8, Jillian Nicholl9, Jozef Gecz1,2, Cheryl Shoubridge1,2.   

Abstract

Copy number variations are a common cause of intellectual disability (ID). Determining the contribution of copy number variants (CNVs), particularly gains, to disease remains challenging. Here, we report four males with ID with sub-microscopic duplications at Xp11.2 and review the few cases with overlapping duplications reported to date. We established the extent of the duplicated regions in each case encompassing a minimum of three known disease genes TSPYL2, KDM5C and IQSEC2 with one case also duplicating the known disease gene HUWE1. Patients with a duplication encompassing TSPYL2, KDM5C and IQSEC2 without gains of nearby SMC1A and HUWE1 genes have not been reported thus far. All cases presented with ID and significant deficits of speech development. Some patients also manifested behavioral disturbances such as hyperactivity and attention-deficit/hyperactivity disorder. Lymphoblastic cell lines from patients show markedly elevated levels of TSPYL2, KDM5C and SMC1A, transcripts consistent with the extent of their CNVs. The duplicated region in our patients contains several genes known to escape X-inactivation, including KDM5C, IQSEC2 and SMC1A. In silico analysis of expression data in selected gene expression omnibus series indicates that dosage of these genes, especially IQSEC2, is similar in males and females despite the fact they escape from X-inactivation in females. Taken together, the data suggest that gains in Xp11.22 including IQSEC2 cause ID and are associated with hyperactivity and attention-deficit/hyperactivity disorder, and are likely to be dosage-sensitive in males.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26059843      PMCID: PMC4757771          DOI: 10.1038/ejhg.2015.123

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  54 in total

Review 1.  Neurobehavioral phenotype of Klinefelter syndrome.

Authors:  D H Geschwind; K B Boone; B L Miller; R S Swerdloff
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2000

Review 2.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

Review 3.  A review of trisomy X (47,XXX).

Authors:  Nicole R Tartaglia; Susan Howell; Ashley Sutherland; Rebecca Wilson; Lennie Wilson
Journal:  Orphanet J Rare Dis       Date:  2010-05-11       Impact factor: 4.123

Review 4.  Pathogenic or not? Assessing the clinical relevance of copy number variants.

Authors:  J Y Hehir-Kwa; R Pfundt; J A Veltman; N de Leeuw
Journal:  Clin Genet       Date:  2013-08-21       Impact factor: 4.438

5.  Transcriptional modification by a CASK-interacting nucleosome assembly protein.

Authors:  Guey-Shin Wang; Chen-Jei Hong; Tsen-Yann Yen; Hsin-Yi Huang; Yvonne Ou; Tzyy-Nan Huang; Wei-Gang Jung; Ting-Yu Kuo; Morgan Sheng; Ting-Fang Wang; Yi-Ping Hsueh
Journal:  Neuron       Date:  2004-04-08       Impact factor: 17.173

6.  Diagnostic exome sequencing identifies two novel IQSEC2 mutations associated with X-linked intellectual disability with seizures: implications for genetic counseling and clinical diagnosis.

Authors:  Stephanie K Gandomi; K D Farwell Gonzalez; M Parra; L Shahmirzadi; J Mancuso; P Pichurin; R Temme; S Dugan; W Zeng; Sha Tang
Journal:  J Genet Couns       Date:  2013-12-04       Impact factor: 2.537

7.  Genomic imbalances in patients with a clinical presentation in the spectrum of Cornelia de Lange syndrome.

Authors:  Cristina Gervasini; Chiara Picinelli; Jacopo Azzollini; Daniela Rusconi; Maura Masciadri; Anna Cereda; Cinzia Marzocchi; Giuseppe Zampino; Angelo Selicorni; Romano Tenconi; Silvia Russo; Lidia Larizza; Palma Finelli
Journal:  BMC Med Genet       Date:  2013-04-03       Impact factor: 2.103

8.  De novo mutations in epileptic encephalopathies.

Authors:  Andrew S Allen; Samuel F Berkovic; Patrick Cossette; Norman Delanty; Dennis Dlugos; Evan E Eichler; Michael P Epstein; Tracy Glauser; David B Goldstein; Yujun Han; Erin L Heinzen; Yuki Hitomi; Katherine B Howell; Michael R Johnson; Ruben Kuzniecky; Daniel H Lowenstein; Yi-Fan Lu; Maura R Z Madou; Anthony G Marson; Heather C Mefford; Sahar Esmaeeli Nieh; Terence J O'Brien; Ruth Ottman; Slavé Petrovski; Annapurna Poduri; Elizabeth K Ruzzo; Ingrid E Scheffer; Elliott H Sherr; Christopher J Yuskaitis; Bassel Abou-Khalil; Brian K Alldredge; Jocelyn F Bautista; Samuel F Berkovic; Alex Boro; Gregory D Cascino; Damian Consalvo; Patricia Crumrine; Orrin Devinsky; Dennis Dlugos; Michael P Epstein; Miguel Fiol; Nathan B Fountain; Jacqueline French; Daniel Friedman; Eric B Geller; Tracy Glauser; Simon Glynn; Sheryl R Haut; Jean Hayward; Sandra L Helmers; Sucheta Joshi; Andres Kanner; Heidi E Kirsch; Robert C Knowlton; Eric H Kossoff; Rachel Kuperman; Ruben Kuzniecky; Daniel H Lowenstein; Shannon M McGuire; Paul V Motika; Edward J Novotny; Ruth Ottman; Juliann M Paolicchi; Jack M Parent; Kristen Park; Annapurna Poduri; Ingrid E Scheffer; Renée A Shellhaas; Elliott H Sherr; Jerry J Shih; Rani Singh; Joseph Sirven; Michael C Smith; Joseph Sullivan; Liu Lin Thio; Anu Venkat; Eileen P G Vining; Gretchen K Von Allmen; Judith L Weisenberg; Peter Widdess-Walsh; Melodie R Winawer
Journal:  Nature       Date:  2013-08-11       Impact factor: 49.962

9.  Refining analyses of copy number variation identifies specific genes associated with developmental delay.

Authors:  Bradley P Coe; Kali Witherspoon; Jill A Rosenfeld; Bregje W M van Bon; Anneke T Vulto-van Silfhout; Paolo Bosco; Kathryn L Friend; Carl Baker; Serafino Buono; Lisenka E L M Vissers; Janneke H Schuurs-Hoeijmakers; Alex Hoischen; Rolph Pfundt; Nik Krumm; Gemma L Carvill; Deana Li; David Amaral; Natasha Brown; Paul J Lockhart; Ingrid E Scheffer; Antonino Alberti; Marie Shaw; Rosa Pettinato; Raymond Tervo; Nicole de Leeuw; Margot R F Reijnders; Beth S Torchia; Hilde Peeters; Brian J O'Roak; Marco Fichera; Jayne Y Hehir-Kwa; Jay Shendure; Heather C Mefford; Eric Haan; Jozef Gécz; Bert B A de Vries; Corrado Romano; Evan E Eichler
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330

10.  Copy number variants (CNVs) analysis in a deeply phenotyped cohort of individuals with intellectual disability (ID).

Authors:  Ying Qiao; Eloi Mercier; Jila Dastan; Jane Hurlburt; Barbara McGillivray; Albert E Chudley; Sandra Farrell; Francois P Bernier; Me Suzanne Lewis; Paul Pavlidis; Evica Rajcan-Separovic
Journal:  BMC Med Genet       Date:  2014-07-16       Impact factor: 2.103

View more
  20 in total

Review 1.  X-chromosome inactivation and escape.

Authors:  Christine M Disteche; Joel B Berletch
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

2.  A novel splicing mutation in the IQSEC2 gene that modulates the phenotype severity in a family with intellectual disability.

Authors:  Irene Madrigal; Maria Isabel Alvarez-Mora; Jordi Rosell; Laia Rodríguez-Revenga; Olof Karlberg; Sascha Sauer; Ann-Christine Syvänen; Montserrat Mila
Journal:  Eur J Hum Genet       Date:  2016-01-06       Impact factor: 4.246

3.  Systems genetics analysis of pharmacogenomics variation during antidepressant treatment.

Authors:  M B Madsen; L J A Kogelman; H N Kadarmideen; H B Rasmussen
Journal:  Pharmacogenomics J       Date:  2016-10-18       Impact factor: 3.550

Review 4.  BRAG1/IQSEC2 as a regulator of small GTPase-dependent trafficking.

Authors:  Amber Petersen; Joshua C Brown; Nashaat Z Gerges
Journal:  Small GTPases       Date:  2018-01-24

5.  Gonadal mosaicism of a novel IQSEC2 variant causing female limited intellectual disability and epilepsy.

Authors:  Lisa J Ewans; Michael Field; Ying Zhu; Gillian Turner; Melanie Leffler; Marcel E Dinger; Mark J Cowley; Michael F Buckley; Ingrid E Scheffer; Matilda R Jackson; Tony Roscioli; Cheryl Shoubridge
Journal:  Eur J Hum Genet       Date:  2017-03-15       Impact factor: 4.246

6.  Solving for X: Evidence for sex-specific autism biomarkers across multiple transcriptomic studies.

Authors:  Samuel C Lee; Thomas P Quinn; Jerry Lai; Sek Won Kong; Irva Hertz-Picciotto; Stephen J Glatt; Tamsyn M Crowley; Svetha Venkatesh; Thin Nguyen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-12-06       Impact factor: 3.568

7.  The Y-located proto-oncogene TSPY exacerbates and its X-homologue TSPX inhibits transactivation functions of androgen receptor and its constitutively active variants.

Authors:  Yunmin Li; Dong Ji Zhang; Yun Qiu; Tatsuo Kido; Yun-Fai Chris Lau
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

Review 8.  X-chromosome regulation and sex differences in brain anatomy.

Authors:  Armin Raznahan; Christine M Disteche
Journal:  Neurosci Biobehav Rev       Date:  2020-11-07       Impact factor: 8.989

9.  Tspyl2 Loss-of-Function Causes Neurodevelopmental Brain and Behavior Abnormalities in Mice.

Authors:  Qi Li; Siu Yuen Chan; Kwun K Wong; Ran Wei; Yu On Leung; Abby Y Ding; Tomy C K Hui; Charlton Cheung; Siew E Chua; Pak C Sham; Ed X Wu; Grainne M McAlonan
Journal:  Behav Genet       Date:  2016-01-29       Impact factor: 2.805

10.  Novel Missense Mutation A789V in IQSEC2 Underlies X-Linked Intellectual Disability in the MRX78 Family.

Authors:  Vera M Kalscheuer; Victoria M James; Miranda L Himelright; Philip Long; Renske Oegema; Corinna Jensen; Melanie Bienek; Hao Hu; Stefan A Haas; Maya Topf; A Jeannette M Hoogeboom; Kirsten Harvey; Randall Walikonis; Robert J Harvey
Journal:  Front Mol Neurosci       Date:  2016-01-11       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.